INTERRELATION OF ATHEROSCLEROSIS RISK FACTORS AND CENTRAL NERVOUS SYSTEM CONDITION IN PATIENTS WITH CHRONIC HEART FAILURE OF ISCHEMIC ORIGIN

Aim. Chronic heart failure is one of the factors of the development and progression of cognitive disorders. To study the relationships between risk factors of atherosclerosis and condition of the central nervous system in patients with chronic heart failure of ischemic etiology.

Material and methods. Cognitive tests, echocardiography, ultrasound investigation of carotid arteries, MRI of the brain and measurement of homocystein, CRP, lipid profile in venous blood were performed in 57 patients with I–IV functional class of chronic heart failure. Program STATISTICA7 (methods of incremental regression analysis) were used to assess the results.

Results. Strong interactions between worsening of cognitive functions and increase of homocystein level, increase of thickness of IMC, decrease of low-density lipoprotein cholesterol were revealed. Decrease of thickness of the cerebral grey matter and increase of apparent diffusion coefficient of water molecules of the brain were associated with increased C-reactive protein levels, cholesterol of low density lipoproteins and high-density lipoproteins and with decrease of the thickness of carotid IMC. The decrease of thickness of middle legs of cerebellum was associated with reduced levels of low-density and high-density lipoprotein cholesterol.

Conclusion. The relationship between risk factors of atherosclerosis, cognitive functions, and morphological changes of the brain was revealed.

chronic heart failure, Ischemic heart disease, risk factors of atherosclerosis, cognitive functions, thickness of grey matter of the brain, the apparent diffusion coefficient of water molecules in the brain

1. Skvorcova VI, Stahovskaja LV, Gudkova VV, et al. Chronic Ischemic disease of the brain. Consilium medicum 2006; 1 (3); 92–4. Russian (Скворцова В.И., Стаховская Л.В., Гудкова В.В. и др. Хроническая ишемия головного мозга. Consilium medicum 2006; 1 (3); 92–4).

2. Zaharov VV. Chronic cerebral ischemic insufficiency. Difficult patient 2005; 12; 54–5. Russian (Захаров В.В. Хроническая сосудистая мозговая недостаточность. Трудный пациент 2005; 12; 54–5).

3. McMurray JJV (Chairperson), Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur Heart J 2012; 33; 1787–847.

4. Akimova NS, Martynovich TV, Persashvili DG, et al. Relationship between severity of CHF, diffusion of water molecules and thickness of white matter of the brain and cognitive functions. Fundamental studies 2012; 10 (2); 223–7. Russian (Акимова Н. С., Мартынович Т.В., Персашвили Д. Г. и др. Взаимосвязь тяже- сти хронической сердечной недостаточности с толщиной белого вещества головного мозга, коэффициентами диффузии молекул воды и когнитивными функциями. Фундаментальные исследования 2012; 10 (2); 223–7).

5. Cardenas VA, Reed B, Chao LL, et al. Assotiations among vascular risk factors, carotid atherosclerosis and cortical volume and thickness in older adults. Stroke 2012; 43 (11); 2865–70.

6. Firbank MJ, Narayan SK, Saxby BK, et al. Homocysteine is assotiated with hippocampal and white matter atrophy in older subjects with mild hypertension. Internal Psychogeriatry 2010; 22 (5); 804–11.

7. Corrado E, Rizzo M, Coppola G, et al. An update on the role of markers of inflammation in atherosclerosis. J Atheroscler Thromb 2010; 1 (17): 1–11.

8. Pico F, Dufouil C, Lévy C, et al. Longitudinal study of carotid atherosclerosis and white matter hyperintensities: the EVA — MRI cohort. Cerebrovasc dis 2012; 14 (2); 109–15.

9. Lee PH, Lim TS, Shin HW, et al. Serum cholesterol levels and the risk of multiple system atrophy: a case-control study. Movement Disorders 2009; 15; 24 (5): 752–8.

10. Soran H, Hama S, Yadav R, et al. HDL functionality. Curr Opin Lipidol 2012; 23 (4); 353–66.

11. Peter A. Rinkk. Magnetic resonance in medicine. M.: “Gjeotar-med” 2003; 248 p. Russian (Петер А. Ринкк. Магнитный резонанс в медицине. М.: “Гэотар-мед” 2003; 248 с).

12. Ostroumova OD, Desnickaja IV. The influence of Rozuvastatin on cognitive functions. Consilium medicum 2007; 1 (2); 61–3. Russian (Остроумова О.Д., Десницкая И.В. Влияние Розувастатина на когнитивные функции. Consilium medicum 2007; 1 (2); 61–3).

13. Karimov RN, Shvarc JuG. Statistics for doctors, biologists and not only… Part 2. How to study relationships. Printing house of Saratov State medical University 2009; 188 p. Russian (Каримов Р. Н., Шварц Ю. Г. Статистика для врачей, биологов и не только… Часть 2. Как изучать связи. Изд-во Саратовского мед. унив-та 2009; 188 с).